Randomized trial of a multidisciplinary lifestyle intervention in HIV-infected patients with moderate-high cardiovascular risk
- 1 March 2016
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 246, 301-308
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- HIV Infection and Coronary Heart Disease: An Intersection of EpidemicsThe Journal of Infectious Diseases, 2012
- Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndromeAIDS, 2012
- Dietary Intervention Prevents Dyslipidemia Associated With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1–Infected IndividualsJACC, 2012
- Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General PopulationClinical Infectious Diseases, 2011
- Management of dyslipidemia in HIV-infected patientsClinical Lipidology, 2011
- HIV type 1 infection, and not short-term HAART, induces endothelial dysfunctionAIDS, 2009
- Reduction in circulating markers of endothelial dysfunction in HIV‐infected patients during antiretroviral therapyHIV Medicine, 2009
- Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2007
- Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndromeAIDS, 2006
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002